More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018 by Nancy Fliesler, Harvard Medical School
Hematopoietic stem cells. Credit: Harvard Medical School

Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists have long focused on capturing HSCs' emergence in the embryo, hoping to recreate the process in the lab to provide a source of therapeutic blood cells.

But in the embryo, oddly enough, blood development unfolds differently. The first to show up are already partly differentiated. These so-called "committed progenitors" give rise only to erythroid and myeloid cells—not lymphoid cells like the immune system's B and T lymphocytes.

Now research led by Harvard Medical School Dean George Q. Daley sheds light on this process.

Researchers in Daley's lab, part of Boston Children's Hospital's Stem Cell Program, wanted to know: Does nature deliberately suppress blood cell multipotency in early embryonic development? And could this offer clues about how to reinstate multipotency and more readily generate different blood cell types?

To test these ideas, Daley, study first author Linda Vo, a former graduate student in Daley's lab, and their colleagues started out by creating committed myelo-erythroid progenitors in the lab from induced pluripotent stem (iPS) cells—adult cells reprogrammed to the earliest state of differentiation. They then screened these cells for factors that suppress multipotency, using short hairpin RNAs to knock down expression of 20 different proteins, one by one.

EZH1: A target for blood cell creation?

As reported Jan. 17 in Nature, the screen came up positive for a protein called EZH1. When it was knocked down, the progenitors gained the ability to differentiate into B and T cells. The team then went on to show that mouse embryos deficient in EZH1 generated HSCs earlier in development and more robustly.

Further experiments showed that EZH1 acts to suppress the expression of genes involved in HSC, lymphoid cell development and T-cell activation.

"EZH1 is the molecular clue to how multipotency is repressed in embryonic blood progenitors," said Daley, who recently led the first successful effort to create HSCs and other blood progenitors from iPS cells.

"These insights not only help to explain a fascinating conundrum in developmental biology but will contribute to our ability to engineer HSCs and T cell populations in vitro. That, in turn, could advance creation of 'off the shelf' T for immunotherapy."

While we now know how multipotency is repressed, why it's suppressed remains an open question. "Embryos need to carry oxygen and some myeloid cell functions, but they don't need lymphocytes because they depend on the maternal immune system," Daley said. "Nature is being parsimonious here."

Explore further: Common chemical highly toxic to blood cell precursors

More information: Linda T. Vo et al. Regulation of embryonic haematopoietic multipotency by EZH1, Nature (2018). DOI: 10.1038/nature25435

Related Stories

Common chemical highly toxic to blood cell precursors

June 24, 2016
Malaysian scientists have provided evidence that a widely used chemical is more toxic to certain blood cell precursors in the bone marrow than to others.

Study unlocks origins of blood stem cells

December 9, 2011
A research team led by Nancy Speck, PhD, professor of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, has discovered a molecular marker for the immediate precursors of ...

Blood vessel cells improve the conversion of pluripotent stem cells to blood lineages

February 9, 2015
Hematopoietic stem cells (HSCs) can differentiate into all of the different types of cells that comprise the blood and immune cell lineages. HSC transplantation is the only effective treatment for certain blood disorders; ...

Approaching a decades-old goal: Making blood stem cells from patients' own cells

May 17, 2017
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body. The advance, published ...

Stem cell study finds source of earliest blood cells during development

March 21, 2014
Hematopoietic stem cells are now routinely used to treat patients with cancers and other disorders of the blood and immune systems, but researchers knew little about the progenitor cells that give rise to them during embryonic ...

Recommended for you

New blood test to detect liver damage in under an hour

May 24, 2018
A quick and robust blood test that can detect liver damage before symptoms appear has been designed and verified using clinical samples by a team from UCL and University of Massachusetts.

Selective neural connections can be reestablished in retina after injury, study finds

May 24, 2018
The brain's ability to form new neural connections, called neuroplasticity, is crucial to recovery from some types of brain injury, but this process is hard to study and remains poorly understood. A new study of neural circuit ...

Space-like gravity weakens biochemical signals in muscle formation

May 23, 2018
Astronauts go through many physiological changes during their time in spaceflight, including lower muscle mass and slower muscle development. Similar symptoms can occur in the muscles of people on Earth's surface, too. In ...

Eating at night, sleeping by day swiftly alters key blood proteins

May 21, 2018
Staying awake all night and sleeping all day for just a few days can disrupt levels and time of day patterns of more than 100 proteins in the blood, including those that influence blood sugar, energy metabolism, and immune ...

Hotter bodies fight infections and tumours better—researchers show how

May 21, 2018
The hotter our body temperature, the more our bodies speed up a key defence system that fights against tumours, wounds or infections, new research by a multidisciplinary team of mathematicians and biologists from the Universities ...

Deep space radiation treatment reboots brain's immune system

May 21, 2018
Planning a trip to Mars? You'll want to remember your anti-radiation pills.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.